1-1 of 1
Brian Thomson
Close
Sort by
Journal Articles

Optec: A Phase 2 Study to Evaluate Outpatient Administration of Teclistamab, a BCMA-Targeting Bispecific Antibody, in Patients with Multiple Myeloma

Robert M. Rifkin, Jeff P. Sharman, Jessica Fowler, Thomas S. Lin, Brian Thomson, Jesus G. Berdeja
Journal: Blood
Blood (2023) 142 (Supplement 1): 3374.
https://doi.org/10.1182/blood-2023-185257
Published: 2023